GE Healthcare To Market India-Developed Portable Heart Monitor
This article was originally published in PharmAsia News
Executive Summary
GE Healthcare's seven-pound MAC 800 heart monitor, which it expects to market in the United States, was the result not of U.S. technology, but of engineers in China and India. The company has been expanding its engineering staff in those countries for just over a decade. Indian engineers developed the MAC 800's forerunner as part of an effort to make a portable diagnostic that Indian physicians could carry into rural villages. The result was a device only a fifth of the size of existing monitors, and is to be marketed in the U.S. by GE for $2,500. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.